{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:35:50Z","timestamp":1782452150381,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T00:00:00Z","timestamp":1554940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.vaccine.2019.04.013","type":"journal-article","created":{"date-parts":[[2019,4,6]],"date-time":"2019-04-06T15:58:56Z","timestamp":1554566336000},"page":"2679-2686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Immunogenicity and protection conferred by an optimized purified inactivated Zika vaccine in mice"],"prefix":"10.1016","volume":"37","author":[{"given":"Val\u00e9rie","family":"Lecouturier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Clotilde","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Carayol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Richier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Boudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Heinrichs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2019.04.013_b0005","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0035-9203(52)90042-4","article-title":"Zika virus. I. isolations and serological specificity","volume":"46","author":"Dick","year":"1952","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.vaccine.2019.04.013_b0010","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3201\/eid2205.160065","article-title":"Phylogeny of Zika virus in western hemisphere, 2015","volume":"22","author":"Lanciotti","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2019.04.013_b0015","doi-asserted-by":"crossref","first-page":"e100220.3","DOI":"10.1371\/journal.pmed.1002203","article-title":"Zika virus infection as a cause of congenital brain abnormalities and Guillain-barr\u00e9 syndrome: systematic review","volume":"14","author":"Krauer","year":"2017","journal-title":"PLoS Med"},{"issue":"10","key":"10.1016\/j.vaccine.2019.04.013_b0020","doi-asserted-by":"crossref","first-page":"4864","DOI":"10.1128\/JVI.00252-16","article-title":"Zika virus: new clinical syndromes and its emergence in the western hemisphere","volume":"90","author":"Lazear","year":"2016","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2019.04.013_b0025","doi-asserted-by":"crossref","first-page":"215","DOI":"10.15585\/mmwr.mm6508e2","article-title":"Transmission of Zika virus through sexual contact with travelers to areas of ongoing transmission - continental United States, 2016","volume":"65","author":"Hills","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10027","key":"10.1016\/j.vaccine.2019.04.013_b0030","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","article-title":"Guillain-Barr\u00e9 syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study","volume":"387","author":"Cao-Lormeau","year":"2016","journal-title":"Lancet"},{"issue":"34","key":"10.1016\/j.vaccine.2019.04.013_b0035","doi-asserted-by":"crossref","first-page":"910","DOI":"10.15585\/mmwr.mm6534e1","article-title":"Guillain-Barre syndrome during ongoing Zika virus transmission - Puerto Rico, Jan \u2013Jul 2016","volume":"65","author":"Dirikov","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2019.04.013_b0040","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/ije\/dyw366","article-title":"Spatial quantification of the world population potentially exposed to Zika virus","volume":"46","author":"Alaniz","year":"2017","journal-title":"Int. J. of Epidemiology"},{"issue":"11","key":"10.1016\/j.vaccine.2019.04.013_b0045","doi-asserted-by":"crossref","first-page":"e0005933","DOI":"10.1371\/journal.pntd.0005933","article-title":"Zika virus: an updated review of competent or naturally infected mosquitoes","volume":"11","author":"Epelboin","year":"2017","journal-title":"Plos Negl Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2019.04.013_b0050","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/14760584.2017.1345309","article-title":"An update on Zika vaccine developments","volume":"16","author":"Durbin","year":"2017","journal-title":"Expert Rev Vaccines"},{"issue":"10","key":"10.1016\/j.vaccine.2019.04.013_b0055","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41579-018-0039-7","article-title":"Zika virus vaccines","volume":"16","author":"Abbink","year":"2018","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2019.04.013_b0060","doi-asserted-by":"crossref","first-page":"13206","DOI":"10.1038\/s41598-018-31375-9","article-title":"Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a live-attenuated Zika virus vaccine","volume":"8","author":"Giel-Moloney","year":"2018","journal-title":"Sci Rep."},{"key":"10.1016\/j.vaccine.2019.04.013_b0065","article-title":"Safety and immunogenicity of an anti-Zika virus DNA vaccine - preliminary Report","author":"Tebas","year":"2017","journal-title":"N Engl J Med"},{"issue":"10120","key":"10.1016\/j.vaccine.2019.04.013_b0070","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(17)33106-9","article-title":"Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials","volume":"391","author":"Modjarrad","year":"2017","journal-title":"Lancet"},{"issue":"7617","key":"10.1016\/j.vaccine.2019.04.013_b0075","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nature18952","article-title":"Vaccine protection against Zika virus from Brazil","volume":"536","author":"Larocca","year":"2016","journal-title":"Nature"},{"issue":"6304","key":"10.1016\/j.vaccine.2019.04.013_b0080","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1126\/science.aah6157","article-title":"Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys","volume":"353","author":"Abbink","year":"2016","journal-title":"Science"},{"issue":"420","key":"10.1016\/j.vaccine.2019.04.013_b0085","doi-asserted-by":"crossref","first-page":"eaao4163","DOI":"10.1126\/scitranslmed.aao4163","article-title":"Durability and correlates of vaccine protection against Zika virus in rhesus monkeys","volume":"9","author":"Abbink","year":"2017","journal-title":"Sci Transl Med"},{"issue":"5","key":"10.1016\/j.vaccine.2019.04.013_b0090","doi-asserted-by":"crossref","first-page":"e0004658","DOI":"10.1371\/journal.pntd.0004658","article-title":"A susceptible mouse model for Zika virus infection","volume":"10","author":"Dowall","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2019.04.013_b0095","doi-asserted-by":"crossref","first-page":"e0005704","DOI":"10.1371\/journal.pntd.0005704","article-title":"Lineage-dependent differences in the disease progression of Zika virus infection in type-I interferon receptor knockout (A129) mice","volume":"11","author":"Dowall","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2019.04.013_b0100","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nm.4322","article-title":"A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models","volume":"23","author":"Shan","year":"2017","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.vaccine.2019.04.013_b0105","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.4269\/ajtmh.16-0111","article-title":"Characterization of a novel murine model to study Zika virus","volume":"94","author":"Rossi","year":"2016","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.vaccine.2019.04.013_b0110","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4269\/ajtmh.2009.80.302","article-title":"Evaluation of interferences between dengue vaccine serotypes in a monkey model","volume":"80","author":"Guy","year":"2009","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.vaccine.2019.04.013_b0115","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.immuni.2017.02.005","article-title":"Prospects for a Zika virus vaccine","volume":"46","author":"Barouch","year":"2017","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.vaccine.2019.04.013_b0120","doi-asserted-by":"crossref","first-page":"46375","DOI":"10.1038\/srep46375","article-title":"Protective efficacy of Zika vaccine in AG129 mouse model","volume":"12","author":"Sumathy","year":"2017","journal-title":"Sci Rep."},{"issue":"5","key":"10.1016\/j.vaccine.2019.04.013_b0125","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.chom.2016.03.010","article-title":"A Mouse Model of Zika Virus Pathogenesis","volume":"19","author":"Lazear","year":"2016","journal-title":"Cell Host Microbe."},{"issue":"4","key":"10.1016\/j.vaccine.2019.04.013_b0130","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.tmaid.2016.07.002","article-title":"Non-vector-borne transmission of Zika virus: A systematic review","volume":"14","author":"Grischott","year":"2016","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.vaccine.2019.04.013_b0135","doi-asserted-by":"crossref","unstructured":"WHO. Vaccines and vaccination against yellow fever: WHO Position Paper, June 2013\u2014Recommendations. Vaccine 2015;33(1):76\u201377.","DOI":"10.1016\/j.vaccine.2014.05.040"},{"issue":"4","key":"10.1016\/j.vaccine.2019.04.013_b0140","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.cell.2017.04.024","article-title":"Recurrent potent human neutralizing antibodies to Zika virus in Brazil and Mexico","volume":"169","author":"Robbiani","year":"2017","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.vaccine.2019.04.013_b0145","doi-asserted-by":"crossref","first-page":"e92428","DOI":"10.1172\/jci.insight.92428","article-title":"Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infections","volume":"2","author":"Kam","year":"2017","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.vaccine.2019.04.013_b0150","doi-asserted-by":"crossref","first-page":"14769","DOI":"10.1038\/s41598-017-15039-8","article-title":"A Zika vaccine targeting NS1 protein protects immunocompetent adult mice in a lethal challenge model","volume":"7","author":"Brault","year":"2017","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.vaccine.2019.04.013_b0155","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.vaccine.2011.12.034","article-title":"Protective immunity to DENV2 after immunization with a recombinant NS1protein using a genetically detoxified heat-labile toxin as an adjuvant","volume":"30","author":"Amorima","year":"2012","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2019.04.013_b0160","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.4049\/jimmunol.135.4.2805","article-title":"Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48","volume":"135","author":"Schlesinger","year":"1985","journal-title":"J Immunol"},{"issue":"pt 8","key":"10.1016\/j.vaccine.2019.04.013_b0165","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1099\/0022-1317-69-8-2101","article-title":"Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus","volume":"69","author":"Henchal","year":"1988","journal-title":"J Gen Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19304517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19304517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:32:32Z","timestamp":1759401152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19304517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":33,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0264410X19304517"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.04.013","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and protection conferred by an optimized purified inactivated Zika vaccine in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}